Clinical Trial Update: Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants [Phase 4]

View source ↗

Summary

This is an update on a Phase 4 clinical trial evaluating chlorhexidine as the hub antiseptic to prevent catheter-related infections in newborn infants. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Infection

Drugs mentioned

• Chlorhexidine (chlorhexidine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Catheterization | Phase 4 | Status: UNKNOWN